1Kirsch I. Are drug and placebo effects in depression additive[J]. Biol Psychiatry, 2000,47 (2):99
2Thase ME,Entsuah AR,Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors[J]. Br J Psychiatry,2001,178(3) :234
3Thase ME, Haight BR,Richard N,et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors:a meta-analysis of original data from 7 randomized controlled trials[J]. J Clin Psychiatry, 2005,66(6) :974
4Elkin I,Shea MT,Watkins JT, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments[J]. Arch Gen Psychiatry,1989,46(6) :971
5Dimidjian S, Hollon SD, Dobson KS, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression[J]. J Consult Clin Psychol,2006,74(4) :658
6DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression[J]. Arch Gen Psychiatry, 2005,62 (3) : 409
7Jarrett RB, Schaffer M, Mclntire D, et al. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind,placebo-controlled trial [J]. Arch Gen Psychiatry,1999,56(3) :431
8Murphy GE, Simons AD, Wetzel RD, et al. Cognitive therapy and pharmacotherapy. Singly and together in the treatment of depression[J]. Arch Gen Psychiatry, 1984,41(1):33
9Frank E, Kupfer DJ, Perel JM, et al. Three-year out comes for maintenance therapies in recurrent depression[J]. Arch Gen Psychiatry, 1990,47(7) : 1093
10Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing[J]. JAMA, 2002,287(9) : 1840
